Use of a cyclic tripeptide for improving cellular energy metabolism
The present invention relates to the use of a cyclic peptide comprising the tripeptide reproducing a binding site of fertilin beta to the oocyte integrin, for improving cellular energy metabolism. More particularly, the invention concerns the use of a cyclic peptide comprising the tripeptide FEEc for stimulating the energy metabolism of gametes or embryonic cells in the context of medically assisted procreation (MAP) protocols, in particular promoting the in vitro maturation of the oocyte, the fertilization rate and the birth rate.
1. A method of maturating immature mammalian oocytes in vitro comprising:
contacting the immature mammalian oocytes in vitro with at least one cyclic peptide comprising a cyclic tripeptide F-E-E of SEQ ID NO: 1 with a cyclization linkage between the two end cysteines, thereby maturating the mammalian oocytes.
2. The method of claim 1 , wherein the immature mammalian oocytes are human oocytes.
3. The method of claim 1 , wherein the immature mammalian oocytes are incubated with 1 to 100 μM of cyclic peptide for a period of between 1 minute and 4 days.
4. The method of claim 1 , wherein contacting the immature mammalian oocytes with the cyclic peptide decreases the risks of miscarriage.
5. The method of claim 1 , wherein contacting the immature mammalian oocytes with the cyclic peptide decreases the risks of aneuploidy in the oocyte.
6. The method of claim 5 , wherein the aneuploidy is trisomy.
7. The method of claim 1 , wherein the immature mammalian oocytes are human oocytes from a woman 37 years old or older.
8. The method of claim 1 , wherein the immature mammalian oocytes are human oocytes from a woman under the age of 30.
9. The method of claim 1 , wherein contacting the immature mammalian oocytes with the at least one cyclic peptide improves ploidy of oocytes.